Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Nexo Therapeutics offers treatments for some of cancer's most intractable targets.
Myra Vision develops a treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
ConnectRN is a tech-enabled network built to improve clinicians' lives through access to community, opportunity, and support.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Bliss Bio is a biopharmaceutical company focused on development of tumor targeting and immunotherapy drugs.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
MOMA Therapeutics operates as a biotechnology company.
Arkuda Therapeutics is a pharmaceutical company.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Stablix Therapeutics is a biotechnology company pioneering the field of Targeted Protein Stabilization (TPS).
Cormorant Asset Management has invested in 209 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cormorant Asset Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Life Science. The firm invests across 20 different industry categories.
Among tracked funding rounds, Akero Therapeutics received $366.9M in a Post Ipo Equity round. Cormorant Asset Management's total known invested capital is $23.5B.
Cormorant Asset Management's average investment size is $137.2M across its portfolio of 209 companies.
Recent Cormorant Asset Management portfolio additions include Akero Therapeutics, Clearside Biomedical, Tyra Biosciences, Longboard Pharmaceuticals, Synnovation Therapeutics. These companies were founded in 2020 or later.